scholarly journals Big Data and Artificial Intelligence (AI) are Poised to Transform Infertility Healthcare

2020 ◽  
Author(s):  
Ines de Santiago ◽  
Lukasz Polanski
Keyword(s):  
Artificial Intelligence ◽  
Machine Learning ◽  
Big Data ◽  
Assisted Reproduction ◽  
Clinical Decision Making ◽  
Clinical Medicine ◽  
Clinical Decision ◽  
Poor Quality ◽  
Research Progress ◽  
Successful Outcome

Advances in machine learning (ML) and artificial intelligence (AI) are transforming the way we treat patients in ways not even imagined a few years ago. Cancer research is at the forefront of this movement. Infertility, though not a life-threatening condition, affects around 15% of couples trying for a pregnancy. Increasing availability of large datasets from various sources creates an opportunity to introduce ML and AI into infertility prevention and treatment. At present in the field of assisted reproduction, very little is done in order to prevent infertility from arising, with the main focus put on treatment when often advanced maternal age and low ovarian reserve make it very difficult to conceive. A shift from this disease-centric model to a health centric model in infertility is already taking place with more emphasis on the patient as an active participator in the process. Poor quality and incomplete data as well as biological variability remain the main limitations in the widespread and reliable implementation of AI in the field of reproductive medicine. That said, one of the areas where this technology managed to find a foothold is identification of developmentally competent embryos. More work is required however to learn about ways to improve natural conception, the detection and diagnosis of infertility, and improve assisted reproduction treatments (ART) and ultimately, develop clinically useful algorithms able to adjust treatment regimens in order to assure a successful outcome of either fertility preservation or infertility treatment. Progress in genomics, digital technologies and advances in integrative biology has had a tremendousimpact on research and clinical medicine. With the rise of ‘big data’, artificial intelligence, and the advances in molecular profiling, there is an enormous potential to transform not only scientific research progress, but also clinical decision making towards predictive, preventive, and personalized medicine. In the field of reproductive health, there is now an exciting opportunity to leverage these technologies and develop more sophisticated approaches to diagnose and treat infertility disorders. In this review, we present a comprehensive analysis and interpretation of different innovation forces that are driving the emergence of a system approach to the infertility sector. Here we discuss recent influential work and explore the limitations of the use of Machine Learning models in this rapidly developing area.

scholarly journals Can Artificial Intelligence Improve the Management of Pneumonia

2020 ◽  
Vol 9 (1) ◽  
pp. 248 ◽  
Author(s):  
Mariana Chumbita ◽  
Catia Cillóniz ◽  
Pedro Puerta-Alcalde ◽  
Estela Moreno-García ◽  
Gemma Sanjuan ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Machine Learning ◽  
Neural Networks ◽  
Clinical Decision Making ◽  
Empirical Therapy ◽  
Clinical Decision ◽  
Mortality Prediction ◽  
Mathematical Functions ◽  
Computational Performance ◽  
Decision Making Processes

The use of artificial intelligence (AI) to support clinical medical decisions is a rather promising concept. There are two important factors that have driven these advances: the availability of data from electronic health records (EHR) and progress made in computational performance. These two concepts are interrelated with respect to complex mathematical functions such as machine learning (ML) or neural networks (NN). Indeed, some published articles have already demonstrated the potential of these approaches in medicine. When considering the diagnosis and management of pneumonia, the use of AI and chest X-ray (CXR) images primarily have been indicative of early diagnosis, prompt antimicrobial therapy, and ultimately, better prognosis. Coupled with this is the growing research involving empirical therapy and mortality prediction, too. Maximizing the power of NN, the majority of studies have reported high accuracy rates in their predictions. As AI can handle large amounts of data and execute mathematical functions such as machine learning and neural networks, AI can be revolutionary in supporting the clinical decision-making processes. In this review, we describe and discuss the most relevant studies of AI in pneumonia.

scholarly journals Predicting infection and sepsis; what predictors have been used to train machine learning algorithms? A systematic review

2021 ◽  
Vol 29 (Supplement_1) ◽  
pp. i18-i18
Author(s):  
N Hassan ◽  
R Slight ◽  
D Weiand ◽  
A Vellinga ◽  
G Morgan ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Machine Learning ◽  
Systematic Review ◽  
Decision Making ◽  
Quality Assessment ◽  
Clinical Decision Making ◽  
Data Extraction ◽  
Learning Algorithms ◽  
Clinical Decision ◽  
Machine Learning Algorithms

Abstract Introduction Sepsis is a life-threatening condition that is associated with increased mortality. Artificial intelligence tools can inform clinical decision making by flagging patients who may be at risk of developing infection and subsequent sepsis and assist clinicians with their care management. Aim To identify the optimal set of predictors used to train machine learning algorithms to predict the likelihood of an infection and subsequent sepsis and inform clinical decision making. Methods This systematic review was registered in PROSPERO database (CRD42020158685). We searched 3 large databases: Medline, Cumulative Index of Nursing and Allied Health Literature, and Embase, using appropriate search terms. We included quantitative primary research studies that focused on sepsis prediction associated with bacterial infection in adult population (>18 years) in all care settings, which included data on predictors to develop machine learning algorithms. The timeframe of the search was 1st January 2000 till the 25th November 2019. Data extraction was performed using a data extraction sheet, and a narrative synthesis of eligible studies was undertaken. Narrative analysis was used to arrange the data into key areas, and compare and contrast between the content of included studies. Quality assessment was performed using Newcastle-Ottawa Quality Assessment scale, which was used to evaluate the quality of non-randomized studies. Bias was not assessed due to the non-randomised nature of the included studies. Results Fifteen articles met our inclusion criteria (Figure 1). We identified 194 predictors that were used to train machine learning algorithms to predict infection and subsequent sepsis, with 13 predictors used on average across all included studies. The most significant predictors included age, gender, smoking, alcohol intake, heart rate, blood pressure, lactate level, cardiovascular disease, endocrine disease, cancer, chronic kidney disease (eGFR<60ml/min), white blood cell count, liver dysfunction, surgical approach (open or minimally invasive), and pre-operative haematocrit < 30%. These predictors were used for the development of all the algorithms in the fifteen articles. All included studies used artificial intelligence techniques to predict the likelihood of sepsis, with average sensitivity 77.5±19.27, and average specificity 69.45±21.25. Conclusion The type of predictors used were found to influence the predictive power and predictive timeframe of the developed machine learning algorithm. Two strengths of our review were that we included studies published since the first definition of sepsis was published in 2001, and identified factors that can improve the predictive ability of algorithms. However, we note that the included studies had some limitations, with three studies not validating the models that they developed, and many tools limited by either their reduced specificity or sensitivity or both. This work has important implications for practice, as predicting the likelihood of sepsis can help inform the management of patients and concentrate finite resources to those patients who are most at risk. Producing a set of predictors can also guide future studies in developing more sensitive and specific algorithms with increased predictive time window to allow for preventive clinical measures.

scholarly journals A Review of Current Applications of Artificial Intelligence and Machine Learning in Medical Science

2021 ◽  
pp. 316-325
Author(s):  
Jayant Kumar A Rathod ◽  
Naveen Bhavani ◽  
Prenita Prinsal Saldanha ◽  
Preethi M Rao ◽  
Prasad Patil
Keyword(s):  
Artificial Intelligence ◽  
Machine Learning ◽  
Decision Making ◽  
Clinical Decision Making ◽  
Medical Science ◽  
Clinical Decision ◽  
Medical Sciences ◽  
Data Set ◽  
Time Problem ◽  
The Impact

Artificial Intelligence and Machine Learning are two fields that are causing substantial development in every field specifically in the field of medical sciences; for the stupendous potential that it can provide to assist the clinicians, researchers, in clinical decision making, automate time consuming procedures, medical imaging, and more. Most implementations of AI/ML rely on static data set, and this where the big data steps in. That is, these models are developed and trained on a data set that is already recorded and have been diligently reviewed for accuracy; leading to a precise decision-making process. Experts foresee that AI/ML based overarching care system will develop high-quality patient care and innovative research, aiding advanced decision support tools. In this paper we shall realize what are the current devices that are build and are being used for real time problem solving, also discuss the impact of Software as a Medical Device (SAMD) in future of medical sciences. [2,3,11]

scholarly journals Accessing Artificial Intelligence for Clinical Decision-Making

2021 ◽  
Vol 3 ◽  
Author(s):  
Chris Giordano ◽  
Meghan Brennan ◽  
Basma Mohamed ◽  
Parisa Rashidi ◽  
François Modave ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Decision Making ◽  
Patient Care ◽  
Clinical Decision Making ◽  
Clinical Medicine ◽  
Clinical Decision ◽  
Disruptive Innovation ◽  
Decision Makers ◽  
Data Sets ◽  
Sequential Decision

Advancements in computing and data from the near universal acceptance and implementation of electronic health records has been formative for the growth of personalized, automated, and immediate patient care models that were not previously possible. Artificial intelligence (AI) and its subfields of machine learning, reinforcement learning, and deep learning are well-suited to deal with such data. The authors in this paper review current applications of AI in clinical medicine and discuss the most likely future contributions that AI will provide to the healthcare industry. For instance, in response to the need to risk stratify patients, appropriately cultivated and curated data can assist decision-makers in stratifying preoperative patients into risk categories, as well as categorizing the severity of ailments and health for non-operative patients admitted to hospitals. Previous overt, traditional vital signs and laboratory values that are used to signal alarms for an acutely decompensating patient may be replaced by continuously monitoring and updating AI tools that can pick up early imperceptible patterns predicting subtle health deterioration. Furthermore, AI may help overcome challenges with multiple outcome optimization limitations or sequential decision-making protocols that limit individualized patient care. Despite these tremendously helpful advancements, the data sets that AI models train on and develop have the potential for misapplication and thereby create concerns for application bias. Subsequently, the mechanisms governing this disruptive innovation must be understood by clinical decision-makers to prevent unnecessary harm. This need will force physicians to change their educational infrastructure to facilitate understanding AI platforms, modeling, and limitations to best acclimate practice in the age of AI. By performing a thorough narrative review, this paper examines these specific AI applications, limitations, and requisites while reviewing a few examples of major data sets that are being cultivated and curated in the US.

scholarly journals Rummage of Machine Learning Algorithms in Cancer Diagnosis

2021 ◽  
Vol 12 (1) ◽  
pp. 1-15
Author(s):  
Prashant Johri ◽  
Vivek sen Saxena ◽  
Avneesh Kumar
Keyword(s):  
Artificial Intelligence ◽  
Machine Learning ◽  
Clinical Decision Making ◽  
Learning Algorithms ◽  
Clinical Decision ◽  
Machine Learning Algorithms ◽  
Healthcare Sector ◽  
Healthcare Data ◽  
Digital Imaging Technology ◽  
Health Studies

With the continuous improvement of digital imaging technology and rapid increase in the use of digital medical records in last decade, artificial intelligence has provided various techniques to analyze these data. Machine learning, a subset of artificial intelligence techniques, provides the ability to learn from past and present and to predict the future on the basis of data. Various AI-enabled support systems are designed by using machine learning algorithms in order to optimize and computerize the process of clinical decision making and to bring about a massive archetype change in the healthcare sector such as timely identification, revealing and treatment of disease, as well as outcome prediction. Machine learning algorithms are implemented in the healthcare sector and helped in diagnosis of critical illness such as cancer, neurology, cardiac, and kidney disease as well as with easing in anticipation of disease progression. By applying and executing machine learning algorithms over healthcare data, one can evaluate, analyze, and generate the results that can be used not only to advance the prior health studies but also to aid in forecasting a patient's chances of developing of various diseases. The aim in this article is to present an overview of machine learning and to cover various algorithms of machine learning and their present implementation in the healthcare sector.

Machine learning in clinical decision making

Med ◽  
2021 ◽  
Author(s):  
Lorenz Adlung ◽  
Yotam Cohen ◽  
Uria Mor ◽  
Eran Elinav
Keyword(s):  
Machine Learning ◽  
Decision Making ◽  
Clinical Decision Making ◽  
Clinical Decision

scholarly journals AI and Big Data in Healthcare: Towards a More Comprehensive Research Framework for Multimorbidity

2021 ◽  
Vol 10 (4) ◽  
pp. 766 ◽  
Author(s):  
Ljiljana Trtica Majnarić ◽  
František Babič ◽  
Shane O’Sullivan ◽  
Andreas Holzinger
Keyword(s):  
Big Data ◽  
Clinical Decision Making ◽  
Big Data Analytics ◽  
Clinical Decision ◽  
Radical Change ◽  
Research Approach ◽  
Classification Problems ◽  
Care Needs ◽  
Healthcare Settings ◽  
Interaction Factors

Multimorbidity refers to the coexistence of two or more chronic diseases in one person. Therefore, patients with multimorbidity have multiple and special care needs. However, in practice it is difficult to meet these needs because the organizational processes of current healthcare systems tend to be tailored to a single disease. To improve clinical decision making and patient care in multimorbidity, a radical change in the problem-solving approach to medical research and treatment is needed. In addition to the traditional reductionist approach, we propose interactive research supported by artificial intelligence (AI) and advanced big data analytics. Such research approach, when applied to data routinely collected in healthcare settings, provides an integrated platform for research tasks related to multimorbidity. This may include, for example, prediction, correlation, and classification problems based on multiple interaction factors. However, to realize the idea of this paradigm shift in multimorbidity research, the optimization, standardization, and most importantly, the integration of electronic health data into a common national and international research infrastructure is needed. Ultimately, there is a need for the integration and implementation of efficient AI approaches, particularly deep learning, into clinical routine directly within the workflows of the medical professionals.

scholarly journals Blockchain Disrupting Fintech and the Banking System

Proceedings ◽  
2021 ◽  
Vol 74 (1) ◽  
pp. 24
Author(s):  
Eduard Alexandru Stoica ◽  
Daria Maria Sitea
Keyword(s):  
Artificial Intelligence ◽  
Machine Learning ◽  
Big Data ◽  
Financial Institutions ◽  
New World ◽  
Great Part ◽  
Banking System ◽  
Daily Activities ◽  
Blockchain Technology ◽  
Almost All

Nowadays society is profoundly changed by technology, velocity and productivity. While individuals are not yet prepared for holographic connection with banks or financial institutions, other innovative technologies have been adopted. Lately, a new world has been launched, personalized and adapted to reality. It has emerged and started to govern almost all daily activities due to the five key elements that are foundations of the technology: machine to machine (M2M), internet of things (IoT), big data, machine learning and artificial intelligence (AI). Competitive innovations are now on the market, helping with the connection between investors and borrowers—notably crowdfunding and peer-to-peer lending. Blockchain technology is now enjoying great popularity. Thus, a great part of the focus of this research paper is on Elrond. The outcomes highlight the relevance of technology in digital finance.

scholarly journals Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer

2021 ◽  
Author(s):  
E. Amiri Souri ◽  
A. Chenoweth ◽  
A. Cheung ◽  
S. N. Karagiannis ◽  
S. Tsoka
Keyword(s):  
Breast Cancer ◽  
Machine Learning ◽  
Clinical Decision Making ◽  
Histological Grade ◽  
Tumour Size ◽  
Clinical Decision ◽  
Gene Signature ◽  
Risk Classification ◽  
Breast Cancers ◽  
Grade 3

Abstract Background Prognostic stratification of breast cancers remains a challenge to improve clinical decision making. We employ machine learning on breast cancer transcriptomics from multiple studies to link the expression of specific genes to histological grade and classify tumours into a more or less aggressive prognostic type. Materials and methods Microarray data of 5031 untreated breast tumours spanning 33 published datasets and corresponding clinical data were integrated. A machine learning model based on gradient boosted trees was trained on histological grade-1 and grade-3 samples. The resulting predictive model (Cancer Grade Model, CGM) was applied on samples of grade-2 and unknown-grade (3029) for prognostic risk classification. Results A 70-gene signature for assessing clinical risk was identified and was shown to be 90% accurate when tested on known histological-grade samples. The predictive framework was validated through survival analysis and showed robust prognostic performance. CGM was cross-referenced with existing genomic tests and demonstrated the competitive predictive power of tumour risk. Conclusions CGM is able to classify tumours into better-defined prognostic categories without employing information on tumour size, stage, or subgroups. The model offers means to improve prognosis and support the clinical decision and precision treatments, thereby potentially contributing to preventing underdiagnosis of high-risk tumours and minimising over-treatment of low-risk disease.

scholarly journals Clinician checklist for assessing suitability of machine learning applications in healthcare

2021 ◽  
Vol 28 (1) ◽  
pp. e100251
Author(s):  
Ian Scott ◽  
Stacey Carter ◽  
Enrico Coiera
Keyword(s):  
Machine Learning ◽  
Large Scale ◽  
Clinical Decision Making ◽  
Improve Patient Care ◽  
Clinical Decision ◽  
Routine Care ◽  
Machine Learning Algorithms ◽  
Clinical Settings ◽  
Machine Learning Applications ◽  
Key Issues

Machine learning algorithms are being used to screen and diagnose disease, prognosticate and predict therapeutic responses. Hundreds of new algorithms are being developed, but whether they improve clinical decision making and patient outcomes remains uncertain. If clinicians are to use algorithms, they need to be reassured that key issues relating to their validity, utility, feasibility, safety and ethical use have been addressed. We propose a checklist of 10 questions that clinicians can ask of those advocating for the use of a particular algorithm, but which do not expect clinicians, as non-experts, to demonstrate mastery over what can be highly complex statistical and computational concepts. The questions are: (1) What is the purpose and context of the algorithm? (2) How good were the data used to train the algorithm? (3) Were there sufficient data to train the algorithm? (4) How well does the algorithm perform? (5) Is the algorithm transferable to new clinical settings? (6) Are the outputs of the algorithm clinically intelligible? (7) How will this algorithm fit into and complement current workflows? (8) Has use of the algorithm been shown to improve patient care and outcomes? (9) Could the algorithm cause patient harm? and (10) Does use of the algorithm raise ethical, legal or social concerns? We provide examples where an algorithm may raise concerns and apply the checklist to a recent review of diagnostic imaging applications. This checklist aims to assist clinicians in assessing algorithm readiness for routine care and identify situations where further refinement and evaluation is required prior to large-scale use.

Sign in / Sign up

Export Citation Format

Share Document